Neurology and Neurosurgery

Episodes 1-14 of 14

• 

  RestartResume

  CV Risk in Patients with Narcolepsy: See the Data

  Medical Industry Feature

  CV Risk in Patients with Narcolepsy: See the Data

• 

  RestartResume

  Early Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care

  Medical Industry Feature

  Early Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care

• 

  RestartResume

   Advancements in Understanding ALS Treatment

  Medical Industry Feature

   Advancements in Understanding ALS Treatment

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Gustavo Suarez Zambrano, MD

    Peer

• 

  RestartResume

  Investigating a gMG Therapy, Part 1: The MG-ADL Results

  Medical Industry Feature

  Investigating a gMG Therapy, Part 1: The MG-ADL Results

  • 

    

    Christyn Edmundson, MD

    Peer

• 

  RestartResume

  Investigating a gMG Therapy, Part 3: Results from the Extension Studies

  Medical Industry Feature

  Investigating a gMG Therapy, Part 3: Results from the Extension Studies

  • 

    

    Christyn Edmundson, MD

    Peer

• 

  RestartResume

  Investigating a gMG Therapy, Part 2: The Secondary Endpoint Results, Including MG Symptoms PRO

  Medical Industry Feature

  Investigating a gMG Therapy, Part 2: The Secondary Endpoint Results, Including MG Symptoms PRO

  • 

    

    Christyn Edmundson, MD

    Peer

• 

  RestartResume

  From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice

  Medical Industry Feature

  From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Thomas Brannagan III, MD

    Peer

  • 

    

    Marcus Anthony Urey, MD

    Peer

• 

  RestartResume

  Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights

  Medical Industry Feature

  Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Nitasha Sarswat, MD

    Peer

  • 

    

    Thomas Brannagan III, MD

    Peer

• 

  RestartResume

  Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment

  Medical Industry Feature

  Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Thomas Brannagan III, MD

    Peer

• 

  RestartResume

  Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology

  Medical Industry Feature

  Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lori Guyton, MD

    Peer

  • 

    

    Douglas W. Scharre, MD

    Peer

• 

  RestartResume

  The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease

  Medical Industry Feature

  The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lori Guyton, MD

    Peer

  • 

    

    Douglas W. Scharre, MD

    Peer

• 

  RestartResume

  Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers

  Medical Industry Feature

  Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Carolyn K. Clevenger, DNP

    Peer

  • 

    

    George Grossberg, MD

    Peer

• 

  RestartResume

  Managing NF1 PN with this First FDA-Approved Treatment Option

  Medical Industry Feature

  Managing NF1 PN with this First FDA-Approved Treatment Option

  • 

    

    Sandy Millman

    Peer

  • 

    

    Pinki Prasad, MD

    Peer

• 

  RestartResume

  Patient-Centric Care for Managing Certain Manifestations of VHL Disease

  Medical Industry Feature

  Patient-Centric Care for Managing Certain Manifestations of VHL Disease